Clinical Trial Update: Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating doxycycline as a host-directed therapy to improve lung function and reduce tissue destruction in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Pulmonary Hypertension
• Tuberculosis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis, Acute Coronary Syndrome | Phase 3 | Status: RECRUITING